🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Evaluate the personalized risk after ACS using computational algorithms for coronary hemodynamics - another step to improve outcome by advancing the concept #precision-PCI for the future!

David M. Leistner tommaso gori Barbara Stähli & Stephan Kische discuss emerging evidence in epicardial AND microvascular physiology & treatment pathways for patients with #ischemia with INOCA and CMD. #holisticphysiology #cardioed #interventionalcardiology #abbott

This State-of-the-Art provides a comprehensive assessment of the latest results of randomised controlled rials (RCTs), highlights the current guideline recommendations and sheds light on future directions for the treatment of patients with ACS and MVD. ow.ly/p15W50GNatG

A tailored therapy guided by physiology can improve symptoms and quality of life of women with different INOCA types chief Giovanni Esposito Giuseppe_Tarantini Women As One Daniela Trabattoni Valeria Paradies giulia masiero EAP Cayman Anna Franzone federica serino

terrific web binar on #INOCA #CMD clear and comprehensive, enjoy! Barbara Stähli David M. Leistner tommaso gori Land Ahoy! – The Holistic Physiology Approach | Radcliffe Cardiology radcliffecardiology.com/node/16933

Interventionsakademie Online- 6 spannende Themen- Jetzt anmelden 👍

Concomitant coronary artery disease continues to be a challenge in potential TAVI candidates: a systematic approach.

PCI & TAVR | common scenario, limited data Great slide by Dhaval Kolte, MD, PhD summarizing ongoing trials. at today's American College of Cardiology SCAI case conference on complex PCI thx to excellent team @ajaykirtane Farouc Jaffer MD PhD Poonam Velagapudi @jennifer_rymer CindyGrines, MD Ujjwal Rastogi, MD

Join a leading faculty as they discuss how to simultaneously optimize TAVI and future coronary access. Register now 👉 ow.ly/VyNg50IVwXU #TAVI #TAVR #commissuralalignment #cuspoverlap #ACURATENEO2 #ALIGNWITHNEO2 #COMALIGN Mohamed Abdel-Wahab

#EAPCI board 2022-2024 elections were announced at general assembly Under the guidance of President Emanuele Barbato EAPCIPresident ☀️president Elect Alaide Chieffo chief ☀️secretary Robert Byrne Robert Byrne ☀️treasurer Louise Buchanan Thanks to all of you!!

Medyria PhysioCath got among finalists at the #EuroPCR2022 Innovators Day. What a great opportunity to present the preclinical results of the PhysioCath and to discuss #future directions in invasive #coronaryphisiology with a 🔝 panel of experts.

It was a great privilege to discuss the case of a #woman who waited 13 years to be diagnosed with #CMVD #INOCA with the pioneers Dr. Noel Bairey Merz and Dr. Paolo Camici! European Society of Cardiology #cardiotwitter #ESCCongress Women As One

Breaking news from #ESCCongress2022: just presented by Barbara Stähli and published #SimPub in JACC Journals ➡️ CLEVER-ACS trial - no benefit of everolimus following #STEMI in this multi-center RCT Uniklinik Düsseldorf Unispital_USZ CardioTomLuscher Frank Ruschitzka #Cardiotwitter

Young DGK Deutsche Gesellschaft für Kardiologie Erik Rafflenbeul AGIK #WomeninCardiology #AGIKwomen

In #STEMI patients undergoing #PCI, can mTOR inhibition reduce infarct size or microvascular obstruction? Learn more in #JACC: bit.ly/3NvzR9H Barbara Stähli #CardioTwitter #cvAMI

The FAVOR III Europe Japan randomised trial may determine if QFR-guided coronary artery revascularisation is non-inferior to FFR-guided coronary revascularisation with respect to clinical outcomes. #EAPCI Gianluca Campo ow.ly/2q9B50MspGy